If the 23‑valent pneumococcal polysaccharide vaccine (PPSV23) was administered on a specific date, does the patient still need the 15‑valent pneumococcal conjugate vaccine (PCV15)?

Yes, you still need a pneumococcal conjugate vaccine (PCV15, PCV20, or PCV21) after receiving PPSV23 alone

If PPSV23 was given previously without any prior conjugate vaccine, you should administer a single dose of PCV21, PCV20, or PCV15 at least 1 year after the last PPSV23 dose. This recommendation applies regardless of the patient's age or risk category 1.

The Rationale Behind This Recommendation

The 2024 ACIP guidelines represent a significant shift from older pneumococcal vaccination strategies. Here's why conjugate vaccines are now recommended even after PPSV23:

• Conjugate vaccines provide superior immunologic responses compared to polysaccharide vaccines, including better T-cell dependent immunity and immunologic memory 2
• PPSV23 provides limited duration of protection, making the addition of a conjugate vaccine beneficial for long-term immunity 2
• The newer conjugate vaccines (PCV15, PCV20, PCV21) contain additional serotypes not present in the older PCV13, expanding protection against circulating pneumococcal strains 1

Specific Recommendations by Patient Category

Adults ≥65 Years

• Give PCV21, PCV20, or PCV15 ≥1 year after PPSV23 1
• If PCV15 is chosen, you may follow with PPSV23 ≥1 year later (though this is optional since they already received PPSV23)
• If PCV20 or PCV21 is used, the series is complete and no additional pneumococcal vaccines are needed 1

Adults 19-64 Years with Immunocompromising Conditions, CSF Leak, or Cochlear Implant

• Give PCV21, PCV20, or PCV15 ≥1 year after PPSV23 1
• If PCV15 is selected, follow with PPSV23 ≥8 weeks later (note the shorter interval for high-risk patients)
• PCV20 or PCV21 completes the series 1

Adults 19-64 Years with Chronic Medical Conditions

(Includes: alcoholism, chronic heart/liver/lung disease, diabetes, smoking)

• Give PCV21, PCV20, or PCV15 ≥1 year after PPSV23 1
• If PCV15 is used, follow with PPSV23 ≥1 year later
• Review recommendations again at age 65 1

Choosing Between PCV15, PCV20, and PCV21

PCV20 or PCV21 are preferred over PCV15 because they complete the vaccination series in a single dose and provide broader serotype coverage 1.

Key differences:

• PCV20 and PCV21: Single-dose completion, no need for subsequent PPSV23
• PCV15: Requires follow-up PPSV23 to achieve full serotype coverage (unless patient already received PPSV23, in which case it's optional)
• Important caveat: PCV21 lacks serotype 4, which may be relevant in certain geographic areas with high serotype 4 disease burden (≥30% of cases). In these populations, PCV20 or the PCV15+PPSV23 series may be preferable 1

Common Pitfalls to Avoid

1. Don't assume PPSV23 alone is sufficient: The immunologic advantages of conjugate vaccines make them essential even after polysaccharide vaccination 2

2. Respect the minimum 1-year interval: Giving a conjugate vaccine too soon after PPSV23 may result in hyporesponsiveness. The exception is high-risk patients (immunocompromised, CSF leak, cochlear implant) where 8 weeks is acceptable when using PCV15 followed by PPSV23 1

3. Don't give PCV15 and PPSV23 at the same visit: These must be separated by the appropriate interval 2

4. Document vaccination history carefully: Real-world adherence to complex pneumococcal schedules is poor (only 30.7% concordance in adults ≥65 years) 3. Check both electronic health records and state vaccine registries, as registry data can identify 22% more vaccinations 3

The Bottom Line

The evidence strongly supports adding a conjugate vaccine after PPSV23-only vaccination. This approach leverages the superior immunologic properties of conjugate vaccines while maintaining the broad serotype coverage of PPSV23. PCV20 or PCV21 as a single dose is the most straightforward approach, completing the series without additional vaccines needed 1.